Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes

FEBS Letters

Volumn 579, Issue 28, 2005, Pages 6417-6422

  Kralisch, Susan ^a   Klein, Johannes ^b   Lossner, Ulrike ^a   Bluher, Matthias ^a   Paschke, Ralf ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

3T3 L1 adipocyte; Adipocytokine; Interleukin 6; Obesity; Tissue inhibitor of matrix metalloproteinase 1; Tumor necrosis factor

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN P42; PROTEIN P44; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; TIME; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CHROMANS; CYTOKINES; INTERLEUKIN-6; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; RNA, MESSENGER; THIAZOLIDINEDIONES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 27744476070     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.10.033     Document Type: Article

References (23)

1. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J. Clin. Invest. 106 2000 473 481
2. D.L. Crandall, G.J. Hausman, and J.G. Kral A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives Microcirculation 4 1997 211 232
3. J.L. Beaudeux, P. Giral, E. Bruckert, M.J. Foglietti, and M.J. Chapman Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives Clin. Chem. Lab. Med. 42 2004 121 131
4. E. Maquoi, C. Munaut, A. Colige, D. Collen, and H.R. Lijnen Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity Diabetes 51 2002 1093 1101
5. C. Chavey, B. Mari, M.N. Monthouel, S. Bonnafous, P. Anglard, E. Van Obberghen, and S. Tartare-Deckert Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation J. Biol. Chem. 278 2003 11888 11896
6. C.M. Alexander, S. Selvarajan, J. Mudgett, and Z. Werb Stromelysin-1 regulates adipogenesis during mammary gland involution J. Cell Biol. 152 2001 693 703
7. H.R. Lijnen, D. Demeulemeester, B. Van Hoef, D. Collen, and E. Maquoi Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice Thromb. Haemost. 89 2003 249 255
8. M. Fasshauer, and R. Paschke Regulation of adipocytokines and insulin resistance Diabetologia 46 2003 1594 1603
9. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 adipocytes FEBS Lett. 500 2001 60 63
10. S. Kralisch, J. Klein, U. Lossner, M. Bluher, R. Paschke, M. Stumvoll, and M. Fasshauer Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes Am. J. Physiol. Endocrinol. Metab. 289 2005 E586 E590
11. J. Laborda 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO Nucleic Acids Res. 19 1991 3998
12. J. Klein, M. Fasshauer, M. Ito, B.B. Lowell, M. Benito, and C.R. Kahn Beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes J. Biol. Chem. 274 1999 34795 34802
13. B.M. Spiegelman, and J.S. Flier Obesity and the regulation of energy balance Cell 104 2001 531 543
14. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
15. T. Hayakawa, K. Yamashita, K. Tanzawa, E. Uchijima, and K. Iwata Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum FEBS Lett. 298 1992 29 32
16. L. Guedez, W.G. Stetler-Stevenson, L. Wolff, J. Wang, P. Fukushima, A. Mansoor, and M. Stetler-Stevenson In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1 J. Clin. Invest. 102 1998 2002 2010
17. D. Demeulemeester, D. Collen, and H.R. Lijnen Effect of matrix metalloproteinase inhibition on adipose tissue development Biochem. Biophys. Res. Commun. 329 2005 105 110
18. H.R. Lijnen, E. Maquoi, L.B. Hansen, B. Van Hoef, L. Frederix, and D. Collen Matrix metalloproteinase inhibition impairs adipose tissue development in mice Arterioscler. Thromb. Vasc. Biol. 22 2002 374 379
19. A. Valladares, C. Roncero, M. Benito, and A. Porras TNF-alpha inhibits UCP-1 expression in brown adipocytes via ERKs. Opposite effect of p38MAPK FEBS Lett. 493 2001 6 11
20. J.A. Engelman, A.H. Berg, R.Y. Lewis, M.P. Lisanti, and P.E. Scherer Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes Mol. Endocrinol. 14 2000 1557 1569
21. P.C. Heinrich, I. Behrmann, G. Muller-Newen, F. Schaper, and L. Graeve Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway Biochem. J. 334 1998 297 314
22. P. Peraldi, M. Xu, and B.M. Spiegelman Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling J. Clin. Invest. 100 1997 1863 1869
23. C. Lagathu, J.P. Bastard, M. Auclair, M. Maachi, J. Capeau, and M. Caron Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone Biochem. Biophys. Res. Commun. 311 2003 372 379